Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (131-140 of 206) with videos related to

Pageof 21
Sort By:
Translational Oncology|August 9, 2025
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in GermanyHendrik Dapper, Sabine Oertelt-Prigione, Gertraud Stadler, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2018
Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagusPatrick Sven Plum, Dita Ulase, Elfriede Bollschweiler, et al.
Oncology Research and Treatment|August 21, 2024
Introduction of a New Satellite Model for Participation in Clinical Trials in a Consortial Comprehensive Cancer Center with Four University Hospitals in GermanyJohanna Teloh-Benger, Susanne Isfort, Norbert Gattermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2021
Neoadjuvant and adjuvant end-points in health technology assessment in oncologyNadia Harbeck, Andreas Schneeweiss, Peter Thuss-Patience, et al.
Frontiers in Medicine|September 11, 2024
Seeing the primary tumor because of all the trees: Cancer type prediction on low-dimensional dataJulia Gehrmann, Devina Johanna Soenarto, Kevin Hidayat, et al.
BMC Cancer|January 10, 2019
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinomaPatrick Sven Plum, Florian Gebauer, Max Krämer, et al.
BMC Cancer|June 24, 2020
Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomasJan Rehkaemper, Michael Korenkov, Alexander Quaas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 24, 2024
Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinomaJohannes Bremm, Stefanie Brunner, Erkan Celik, et al.
European Journal of Haematology|October 12, 2016
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspectiveFlorian Kron, Nadine Kutsch, Anna Kostenko, et al.
Pharmacogenetics and Genomics|January 20, 2010
Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFbetaR therapySabine Classen, Christine Muth, Svenja Debey-Pascher, et al.
Pageof 21

Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Translational Oncology|August 9, 2025
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in GermanyHendrik Dapper, Sabine Oertelt-Prigione, Gertraud Stadler, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2018
Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagusPatrick Sven Plum, Dita Ulase, Elfriede Bollschweiler, et al.
Oncology Research and Treatment|August 21, 2024
Introduction of a New Satellite Model for Participation in Clinical Trials in a Consortial Comprehensive Cancer Center with Four University Hospitals in GermanyJohanna Teloh-Benger, Susanne Isfort, Norbert Gattermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2021
Neoadjuvant and adjuvant end-points in health technology assessment in oncologyNadia Harbeck, Andreas Schneeweiss, Peter Thuss-Patience, et al.
Frontiers in Medicine|September 11, 2024
Seeing the primary tumor because of all the trees: Cancer type prediction on low-dimensional dataJulia Gehrmann, Devina Johanna Soenarto, Kevin Hidayat, et al.
BMC Cancer|January 10, 2019
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinomaPatrick Sven Plum, Florian Gebauer, Max Krämer, et al.
BMC Cancer|June 24, 2020
Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomasJan Rehkaemper, Michael Korenkov, Alexander Quaas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 24, 2024
Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinomaJohannes Bremm, Stefanie Brunner, Erkan Celik, et al.
European Journal of Haematology|October 12, 2016
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspectiveFlorian Kron, Nadine Kutsch, Anna Kostenko, et al.
Pharmacogenetics and Genomics|January 20, 2010
Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFbetaR therapySabine Classen, Christine Muth, Svenja Debey-Pascher, et al.
Pageof 21